Loading...

Transplant Monitoring Demand And FDA Clearance Will Drive A Powerful Long Term Upswing

Published
14 Dec 25
Views
0
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
130.8%
7D
-1.0%

Author's Valuation

US$943.3% undervalued intrinsic discount

AnalystHighTarget Fair Value